National and Kapodistrian University of Athens
Monitoring of the decision making competence and adherence of patients with schizophrenia and schizoaffective disorder on lai treatment
Abstract
dc:descriptionIntroduction: Medication nonadherence and treatment discontinuation are common occurrences in schizophrenia. A very helpful approach to improve adherence in schizophrenia is the use of Long-Acting Injectable antipsychotics (LAI). Nevertheless, it may be argued that LAIs are against choice because they take away the patients' ability to control their medication. Patients’ informed consent prior to treatment initiation is an essential component of contemporary clinical practice, but sometimes, patients lack decision-making capacity. Assessment of such capacity is significant in every day clinical practice. Even more important is such assessment in psychiatric patients. The aims of this naturalistic study were to assess patients’, on LAI Antipsychotics, decision making capacity, to monitor patients’ adherence to their prescribed LAI and to compare adherence to LAIs with compliance to oral medication. Purpose: The purpose of this thesis is to investigate patient’s adherence on LAI antipsychotics and to evaluate patient’s decision making capacity.Methods: The study was carried out at 2 Psychiatric Establishments in Greece. In particular, at the Depot Clinic of Agioi Anargyroi Hospital Department of Psychiatry and at the Depot Clinic of Vyronas-Kaisariani Community Mental Health Centre. Inclusion criteria included participants’ age being at least 18 years, having a diagnosis of schizophrenia or schizoaffective disorder as established by the Structured Clinical Interview for DSM-IV, and currently prescribed and taking LAI antipsychotics (regardless of other concomitant medication). Patients were followed up for 26 months at the above mentioned Depot Clinics.Results: Patients sample consisted of 65 patients (55.4% men and 44.6% women) with mean age 44.2 years old (±13.2 years). Patients showed moderate ratings in understanding, reasoning and appreciation indicating good decision making capacity. Clear deficiencies were found for only 1 subject. Regarding adherence almost 100% of the patients sample indicated high compliance rates. Most patients were categorized as having moderate side effects. The compliance rate of patients to their prescribed LAI medication reached 95% versus 35, 9% when on oral medication.Conclusion: Outpatients on LAI formulations are capable of making treatment decisions. The use of long-acting injectable antipsychotics, which improves compliance rates and patient follow-up, should facilitate the management of patients with schizophrenia. Thus, further research is required to elucidate which special population may benefit most from LAI therapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nystazaki, Maria
- Νυσταζάκη, Μαρία
Subjects
dc:subject × 14- Σχιζοφρένεια
- Ενέσιμα αντιψυχωτικά μακράς δράσης
- Συμμόρφωση
- Βουλητική επιλογή
- Schizophrenia
- Long acting antipsychotic medication
- Adherence
- Decision-making capacity
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Άλλες Ιατρικές Επιστήμες
- Medical and Health Sciences
- Health Sciences
- Other Medical Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43766